<DOC>
	<DOCNO>NCT00150735</DOCNO>
	<brief_summary>A double-blind trial compare efficacy safety levetiracetam carbamazepine use monotherapy subject ( ≥ 16 year ) newly recently diagnose suffering epilepsy , experience partial generalize tonic-clonic seizure .</brief_summary>
	<brief_title>Monotherapy With Levetiracetam Newly Diagnosed Patients Suffering From Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsy , Generalized</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subjects newly recently diagnose epilepsy experience unprovoked partial seizure ( IA , IB , IC clear focal origin ) , generalize tonicclonic seizure ( without clear focal origin ) , classifiable accord International Classification Epileptic Seizures . The discrimination IC IIE request inclusion . Subjects least 2 unprovoked seizure separate minimum 48 hour year precede randomization least 1 unprovoked seizure 3 month precede randomization . Subjects confirm diagnosis epilepsy . Male/female subject ( ≥16 year ) . History presence seizure type partial ( IA , IB , IC , clear focal origin ) generalize tonicclonic ( without clear focal origin ) seizures . History presence seizure occur cluster pattern , define repeat seizure occur short period time , i.e . &lt; 20 minute , without function regain 2 ictal event . History , clinical EEG find suggestive idiopathic generalize epilepsy ( IGE ) randomization .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Monotherapy , epilepsy , Levetiracetam , Keppra .</keyword>
</DOC>